Yoshihisa Ishiura

ORCID: 0000-0003-0320-1193
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Pneumonia and Respiratory Infections
  • Lung Cancer Treatments and Mutations
  • COVID-19 diagnosis using AI
  • Inhalation and Respiratory Drug Delivery
  • Respiratory viral infections research
  • Medical Imaging and Pathology Studies
  • Pediatric health and respiratory diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 Clinical Research Studies
  • Lung Cancer Research Studies
  • Ion Channels and Receptors
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Colorectal Cancer Treatments and Studies
  • Mycobacterium research and diagnosis
  • SARS-CoV-2 and COVID-19 Research
  • Occupational and environmental lung diseases
  • Gastroesophageal reflux and treatments
  • Pleural and Pulmonary Diseases
  • Lung Cancer Diagnosis and Treatment
  • Nausea and vomiting management
  • Legionella and Acanthamoeba research
  • Indoor Air Quality and Microbial Exposure
  • Nosocomial Infections in ICU

Kansai Medical University
2019-2025

University Medical Center
2019

Toyama City Hospital
2005-2017

Kouseiren Takaoka Hospital
2006-2009

Kanazawa University Hospital
2006-2009

Komatsu (Japan)
2009

Ishikawa Prefectural Central Hospital
2006-2009

Kanazawa Medical Center
2009

Kanazawa University
1995-2006

Fukui-ken Saiseikai Hospital
2006

Background The real-world efficacy of the P2X3 antagonist gefapixant, a new class antitussive for refractory chronic cough, is not yet fully understood. This study aimed to evaluate usage and response gefapixant in patients with cough. Methods multicentre, retrospective involved cough who visited clinics were prescribed gefapixant. Data collected included baseline demographics, characteristics, degree taste disturbance (both assessed by specialists), course after discontinuation, if...

10.1183/23120541.01037-2024 article EN cc-by-nc ERJ Open Research 2025-01-08

Chronic cough is the only symptom of variant asthma (CVA) and atopic (AC). Cysteinyl leukotriene receptor antagonists have been shown to be effective in CVA, but there are no reports on their effectiveness AC. To evaluate antitussive effect montelukast, a antagonist, CVA Seventy-five patients with chronic received diagnostic bronchodilator therapy oral clenbuterol hydrochloride for 6 days. Of 75 patients, 48 27 met simplified criteria AC, respectively. Patients were randomly divided into 3...

10.2332/allergolint.09-oa-0112 article EN cc-by-nc-nd Allergology International 2010-01-01

The aim of this study was to evaluate the diagnostic utility a novel test kit that could theoretically detect all serogroups Legionella pneumophila for diagnosing pneumonia, in comparison with existing kits.This conducted 16 hospitals Japan from April 2016 December 2018. Three urinary antigen kits were used: (LAC-116), BinaxNOW (Binax), and Q-line Kyokutou (Q-line). In addition, sputum culture nucleic acid detection tests serum antibody performed where possible. accuracy correlations two...

10.1016/j.ijid.2020.10.106 article EN cc-by-nc-nd International Journal of Infectious Diseases 2020-11-08

Chronic cough is one of the most common symptoms respiratory diseases and can adversely affect patients' quality life interfere with social activities, resulting in a significant burden. A survey required to elucidate frequency treatment effect chronic cough. However, clinical studies that cover all Japan have not yet been conducted. Patients who presented lasted longer than 8 weeks visited clinics or hospitals affiliated Cough Society during 2-year study period were registered. total 379...

10.1016/j.resinv.2024.02.017 article EN cc-by Respiratory Investigation 2024-03-23

Mycoplasmapneumoniae is one of the major causative pathogens community-acquired pneumonia (CAP). M. pneumoniae CAP clinically and radiologically distinct from bacterial CAPs. One feature Japanese Respiratory Society (JRS) guidelines a trial to be carried out differentiate between for selection antibiotics. The purpose present study was clarify clinical radiological differences coronavirus disease 2019 (COVID-19) CAP. This conducted at 5 institutions assessed total 210 patients with 956...

10.3390/jcm11040964 article EN Journal of Clinical Medicine 2022-02-12

Abstract Inflammatory mediators are involved in the pathogenesis of airway inflammation, but role prostaglandin I2 (PGI2) remains obscure. This study was designed to investigate PGI2 cough reflex sensitivity asthmatic airway, which is characterized by chronic eosinophilic inflammation. The effect beraprost, a chemically and biologically stable analogue PGI2, on response inhaled capsaicin examined 21 patients with asthma randomized, placebo-controlled cross over study. Capsaicin threshold,...

10.1186/1745-9974-3-2 article EN cc-by Cough 2007-01-12

Indoor formaldehyde (FA) might worsen allergies and be an underlying factor for the increasing incidence severity of asthma; exact mechanism, however, remains unclear.The present study examined effects repeated exposure to FA on methacholine- antigen-induced bronchoconstriction in guinea-pigs vivo.First, non-sensitized were transnasally treated with 0.1 or 1.0% saline three times a week 6 weeks, concentrations methacholine (50, 100, 200 microg/mL) inhaled at 5-min intervals. Second,...

10.1111/j.1365-2222.2003.01826.x article EN Clinical & Experimental Allergy 2003-12-01

Aims Cough, one of the main symptoms bronchial asthma, is a chronic airway inflammatory disease with functionally damaged epithelium. Recently, we established an animal model cough hypersensitivity after antigen challenge and clearly showed protective effect carbocysteine in this model. This study was designed to investigate clinical for sensitivity patients asthma. Methods The effects two orally active mucoregulatory drugs, ambroxol hydrochloride, on response inhaled capsaicin were examined...

10.1046/j.1365-2125.2003.01788.x article EN British Journal of Clinical Pharmacology 2003-06-01

Sotrovimab, an antibody active against severe acute respiratory syndrome coronavirus 2 that neutralizes antibodies, reduced the risk of COVID-19-related hospitalization or death in studies conducted before emergence Omicron variant. The objective this study is to evaluate clinical efficacy sotrovimab patients with mild moderate COVID-19 BA.1 and BA.2 subvariant infections using a propensity score matching method. score-matched cohort population was derived from who received sotrovimab. We...

10.3390/v15061300 article EN cc-by Viruses 2023-05-31

Sinobronchial syndrome is a cause of chronic productive cough. Inflammatory mediators are involved in the pathophysiology Accumulating evidences indicate that cyclooxygenase (COX)-2, one inducible isoforms COX, key element pathophysiological process number inflammatory disorders. However, little known about role COX-2 cough patients with sinobronchial as neutrophilic bronchial inflammation. The effect etodolac, potent inhibitor, on response to inhaled capsaicin was examined 15 randomized,...

10.1186/1745-9974-6-7 article EN cc-by Cough 2010-01-01

Abstract: Cough, a frequent symptom encountered in clinical practice, often has considerable impact on patients’ lives. There is an urgent need to investigate more potent antitussive treatments for chronic refractory cough, particularly atopic which major cause of cough Japan. Previous studies have shown that eosinophilic tracheobronchitis with hypersensitivity sensory nerve C-fibers the pathophysiology cough. Gefapixant first-in-class P2X 3 antagonist recently become available use patients...

10.2147/imcrj.s427098 article EN cc-by-nc International Medical Case Reports Journal 2023-09-01

"Atopic cough" is a new clinical entity that presents with isolated chronic bronchodilator-resistant cough accepted in the Japanese Respiratory Society Guidelines for Management of Cough. The essential features are eosinophilic tracheobronchitis, increased reflex sensitivity and an atopic constitution. It has been suggested activated helper T lymphocytes cytokines which produced by these cells involved pathogenesis, but relationship between cell-derived airway remains unknown.The effect...

10.1055/s-0031-1296510 article EN Arzneimittelforschung 2011-12-15

Bronchial responsiveness to acetaldehyde, a main factor in alcohol-induced bronchoconstriction, and methacholine were compared between 10 subjects with bronchoconstriction 16 asthmatic without alcohol sensitivity. In the alcohol-sensitive group, geometric mean (geometric SEM (GSEM)) of provocative concentration (PC20,meth) acetaldehyde (PC20,acet) causing 20% fall forced expiratory volume one second 0.947 mg x mL(-1) (GSEM 0.139) 21.0 0.112), respectively, which not significantly different...

10.1034/j.1399-3003.1999.14a05.x article EN European Respiratory Journal 1999-07-01

Gastric ulcer and hemorrhage are major complications in patients with chronic respiratory failure, but upper GI endoscopy tends to be avoided because of possible cardiopulmonary events. This study was designed evaluate hypoxemia subsequent cardiac during gastroscopic procedures failure undergoing long-term home oxygen therapy (LHOT).Gastroscopy carried out 10 LHOT age-matched control subjects without pulmonary diseases. Oxygen saturation arrhythmias before gastroscopy were monitored....

10.1055/s-2000-83 article EN Endoscopy 2002-07-26

The increased eicosanoid synthesis has been suggested as the underlying mechanism of chronic productive cough in patients with bronchitis.The effects orally active thromboxane A2 (TxA2) receptor antagonist seratrodast and cysteinyl leukotrienes (cLTs) pranlukast on response to inhaled capsaicin were examined sixteen stable bronchitis. Capsaicin threshold, defined lowest concentration eliciting five or more coughs, was measured an index airway sensitivity.The threshold significantly compared...

10.1080/07853890310010032 article EN Annals of Medicine 2003-01-01

Abstract Aims Cough is a common symptom of bronchial asthma, chronic inflammatory airway disease. Recently, the therapeutic effects selective phosphodiesterase (PDE) inhibitors have been focused on asthma. This study was designed to investigate clinical effect PDE 3 inhibition cough reflex sensitivity in elderly patients with Methods Effects cilostazol, inhibitor, response inhaled capsaicin were examined 11 over 70 years stable asthma randomized, placebo-controlled cross study. Capsaicin...

10.1186/1745-9974-1-11 article EN cc-by Cough 2005-11-24

Abstract Background Late asthmatic response is observed following antigen challenge in actively, but not passively, sensitized guinea pigs. Although cough reflex sensitivity increased after actively pigs, it unknown whether the antigen-induced increase develops passively animals. The aim of this study was to compare inhaled capsaicin an between and Methods Measurement number coughs elicited by increasing concentrations (10 -6 10 -4 M) bronchial responsiveness ascending methacholine, analysis...

10.1186/1745-9974-1-6 article EN cc-by Cough 2005-09-06
Coming Soon ...